Plain-English translation of NCT07392190 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new medication called to see if it helps people with obesity or overweight lose weight when used alongside a diabetes medication they're already taking. About 900 people will participate over roughly 80 weeks. Half will receive the new medication at one of four different doses, and half will receive a placebo (a dummy injection) so researchers can compare results fairly.
Many people taking diabetes medications still struggle with their weight, and doctors need better treatment options. This study aims to determine whether this new injection could help fill that gap and give patients another tool for managing their weight.
You likely qualify if…
You likely don't qualify if…
You would visit the research clinic multiple times over about 80 weeks for check-ins and blood work. You would give yourself a weekly injection of either the new medication or placebo under your skin—similar to how people inject insulin or certain diabetes medicines. Researchers will monitor your weight, overall health, and any side effects throughout the study to see how well the treatment works.
AI-generated summary from trial data · Jul 13, 2026 · Not medical advice
United States